Anti-CD3 Antibody Treatment Induces Hypoglycemia and Super Tolerance to Glucose Challenge in Mice through Enhancing Glucose Consumption by Activated Lymphocytes

Anti-CD3 antibody has been employed for various immune-mediated disorders. However, whether anti-CD3 administration leads to rapid metabolic alternation has not been well investigated. In the current study, we studied how anti-CD3 treatment affected blood glucose levels in mice. We found that anti-C...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Chang-Qing, Chernatynskaya, Anna V., Looney, Benjamin, Wan, Suigui, Clare-Salzler, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987876/
https://www.ncbi.nlm.nih.gov/pubmed/24741590
http://dx.doi.org/10.1155/2014/326708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987876/
https://www.ncbi.nlm.nih.gov/pubmed/24741590
http://dx.doi.org/10.1155/2014/326708

Ejemplares similares